Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.

Publikation

Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.

Wissenschaftlicher Artikel/Review - 27.03.2024

Beck-Schimmer Beatrice, Schadde Erik, Pietsch Urs, Filipovic Miodrag, Dübendorfer-Dalbert Seraina, Fodor Patricia, Hübner Tobias, Schuepbach Reto Andreas, Steiger Peter, David Sascha, Krüger Bernard D, Neff Thomas A, Schläpfer Martin

Zitation

Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dübendorfer-Dalbert S, Fodor P, Hübner T, Schuepbach R, Steiger P, David S, Krüger B, Neff T, Schläpfer M. Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care 2024; 14:41.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Ann Intensive Care 2024; 14

Veröffentlichungsdatum

27.03.2024

ISSN (Druck)

2110-5820

Seiten

Kurzbeschreibung/Zielsetzung

This study aimed to assess a potential organ protective effect of volatile sedation in a scenario of severe inflammation with an early cytokine storm (in particular IL-6 elevation) in patients suffering from COVID-19-related lung injury with invasive mechanical ventilation and sedation.